Amneal Pharmaceuticals, Inc. - News - Press Releases

2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002

Jul 10, 2019

Amneal Pharmaceuticals Announces Restructuring and Costs Savings Plan to Improve Operations and Position the Company for Future Growth

Jul 09, 2019

Amneal to Report Second Quarter 2019 Results on August 8, 2019

Jun 06, 2019

Amneal Pharmaceuticals to Present at Upcoming Investor Conferences

May 15, 2019

Amneal Pharmaceuticals to Present at the RBC Capital Markets Global Healthcare Conference

May 09, 2019

Amneal Reports First Quarter 2019 Financial Results

Apr 08, 2019

Amneal to Report First Quarter 2019 Results on May 9, 2019

Apr 02, 2019

Amneal Names Pradeep Bhadauria as Chief Scientific Officer

Apr 01, 2019

Amneal Announces Agreement with Zentiva to Divest Creo Pharma

Mar 12, 2019

Amneal Announces Launch of Rivastigmine Transdermal System

Mar 06, 2019

Amneal Pharmaceuticals to Present at the Barclays Global Healthcare Conference

Feb 28, 2019

Amneal Reports Fourth Quarter And Full Year 2018 Financial Results

Jan 24, 2019

Amneal to Report Fourth Quarter and Full Year 2018 Results on February 28, 2019

Jan 22, 2019

Amneal Names Accomplished Finance Executive Todd P. Branning As Chief Financial Officer

Jan 14, 2019

Amneal Announces Approval of Rivastigmine Transdermal System

Jan 04, 2019

Amneal Names David A. Buchen Senior Vice President, Chief Legal Officer And Corporate Secretary

© Amneal Pharmaceuticals LLC.

All rights reserved.

Powered By Q4 Inc. 5.23.3.1